Lentiviral Gene Transfer Corrects Immune Abnormalities in XIAP Deficiency
ConclusionGene correction of HSCs recovers XIAP-dependent immune defects and could offer a treatment option for patients with XIAP deficiency.
Source: Journal of Clinical Immunology - Category: Allergy & Immunology Source Type: research
More News: Allergy & Immunology | Gene Therapy | Genetics | Inflammatory Bowel Disease | Stem Cell Therapy | Stem Cells | Transplants | Weight Loss